|
Former Visiting Scholars
Juergen Haas
(University of Cardiff)
Benjamin Hankeln
(University of Regensburg)
Signe Teuber Henriksen
(Danish Technical University)
Stanislav Ivan
(University of Basel)
Nazir Kathri
(Franklin College)
Joshua Konzer
(Albion College)
Peter O'Daniel
(UMBC)
William Pomeranz
(Ithaca College)
Mirjam Sax
(University of Regensburg)
|
Former Group Members
Jerome Amaudrut (Fournier Pharmaceuticals,
France)
Andrew Anderson (South Carolina School of Medicine)
Anthony Bencivenga (U. Pittsburgh, PhD program)
Sonja Braun-Sand (Assist. Prof., University of Colorado)
Brian DiPaolo (Sanofi-Synthelabo,
PA)
Patrick Donoghue (U. Minnesota)
Jaouad El-Bahraoui (CEO,
Net Quest LL, Schaumburg, IL)
Brent Griffith (Washington University, MD Program)
Udo Haberl (AplaGen, Germany)
Chris Harrison (UIUC)
Urs Hirt (Ciba Specialty
Chemicals, Switzerland)
Vijay Iska (Albany Molecular, Singapore)
Marco Jonas (Albany Molecular, NY)
Brian Kadera (Duke University, MD Program)
Artemio Largoza (School
of Medicine, Tulane U.)
Patrick Laine (AppliedResearch
Associates, Fl)
Jonathan Mortison (U. Michigan, Ph.D. program)
A. Roxana Nicolaescu (Serim
Research Corp, IN)
A. Jayne Oliver (Sterne-Kessler-Goldstein-Fox, Washington DC)
Lauren O'Neil (U. Syracruse)
Jonas Oxgaard
(McKinsey)
Mickael Pauvert (AtlanChim, France)
Julie Peller
(Assoc. Prof. Indiana University
Northwest)
Delphine Picot (U. Strassbourg,
France)
Alexander T. Radosevich (Assist. Prof. PennState U.)
G. Devi Reddy (TransTech Pharma, High Point NC)
Nicolas Saettel
(Assist. Prof., Institut Curie, France)
Don B. Sanders ( MD/Ph.D. Program, Northwestern U.
)
Kristen Schaal (OSI Pharmaceuticals, Tarrytown, NY)
Caroline Schmidt (University of Michigan, MD program)
Christo Sevov (UIUC, PhD
program)
David Swinarski (U. Georgia, )
Pierre Tran (University of
Queensland, Australia)
Nick Valley (Northwestern University, Ph.D. program
Viceno Verdolino (ETC
Zürich/Lugano)
Holger Wandel (Bayer Leverkusen, Germany)
Difei Wang (NIH/NCI)
David Young (MD/Ph.D. Program, U. Chicago)
Adam Zabel (Computer Horizons Corp.)
|
